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Abstract.  Multi-layered ("stratified")  epithelia differ 
from one-layered ("simple") polar epithelia by various 
architectural  and functional properties as well as by 
their cytoskeletal complements, notably a set of cyto- 
keratins characteristic  of stratified tissue.  The simple 
epithelial cytokeratins 8 and  18 have so far not been 
detected in any stratified epithelium.  Using specific 
monoclonal antibodies we have noted,  in several but 
not all  samples of stratified epithelia,  including 
esophagus, tongue, exocervix, and vagina,  positive im- 
munocytochemical reactions for cytokeratins 8,  18, and 
19 which in some regions were selective for the basal 
cell layer(s) but extended into suprabasal layers in 
others.  In situ hybridization with different probes 
(riboprobes, synthetic oligonucleotides) for mRNAs of 
cytokeratin 8 on esophageal epithelium has  shown, in 
extended regions,  relatively strong reactivity for 
cytokeratin 8 mRNA in the basal cell layer.  In con- 
trast,  probes to cytokeratin  18 have shown much 
weaker hybridization which, however, was rather 
evenly spread over basal and suprabasal  strata.  These 
results,  which emphasize the importance of in situ hy- 
bridization in studies of gene expression in complex 
tissues,  show that the genes encoding simple epithelial 
cytokeratins can be expressed in stratified epithelia. 
This suggests that continual expression of genes cod- 
ing for simple epithelial cytokeratins is compatible 
with the formation of squamous stratified tissues and 
can occur, at least in basal cell layers,  simultaneously 
with the synthesis of certain stratification-related 
cytokeratins. We also emphasize differences of expres- 
sion and immunoreactivity of these cytokeratins be- 
tween different samples and in different regions of the 
same stratified epithelium and discuss the results in re- 
lation to changes of cytokeratin expression during  fetal 
development of stratified epithelia,  in response to en- 
vironmental  factors and during  the formation of squa- 
mous cell carcinomas. 
PITHELIA and  carcinomas  are  characterized  by the 
presence  of intermediate-sized  filaments  (IFs) ~ of 
the cytokeratin  type (17, 21, 22, 24, 58, 81, 82).  In 
contrast to the other cytoplasmic IF proteins  (vimentin,  des- 
min,  glial  filaments,  and neurofilaments),  the cytokeratins 
are obligatory heteropolymers (16, 37, 49, 79). They form a 
complex multigene family, comprising in human epithelia at 
least 19 different polypeptides (58) and at least another eight 
polypeptides characteristic  of hair-forming  cells  (39,  52). 
Two subfamilies  of cytokeratins  can be distinguished,  i.e., 
the acidic  (type I) and the basic (type II) cytokeratins,  and 
two polypeptide chains  of members of each subfamily  are 
necessary to form the heterotypic tetramer subunit and then 
the IFs (3, 30, 36, 37, 67, 68, 77, 80, 86, 96). The various 
cytokeratin polypeptides of both subfamilies are synthesized 
in  patterns  that are different  in  the diverse epithelial  cell 
1. Abbreviation  used in this paper:  IFs, intermediate-sized  filaments. 
types, and a certain cytokeratin pattern is characteristic  of a 
given epithelial  cell or tissue (10, 20, 58, 68, 83). 
Epithelia represent a group of tissues of various histologi- 
cal appearances and are involved in various functions. Gross- 
ly, they can be grouped into the one-layered  and the multi- 
layered (stratified) epithelia.  One-layered epithelia are either 
simple in cell type complexity, consisting  of rather uniform 
populations  of cells,  which often display architectural  and 
functional  polarity  (hepatocytes,  pancreatic  exocrine  cells, 
tubular epithelia  of kidney), or are comprised of different 
cell types, as in the complex epithelia of, e.g., trachea,  lung, 
bladder, mammary gland, and bladder urothelium.  The cyto- 
keratin patterns of "simple epithelia" are also relatively sim- 
ple, as they form IFs from either only two (8 and 18) or three 
(8, 18, and 19) or four (7, 8, 18, and 19) polypeptides (46, 58, 
68, 83). 
Stratified  epithelia  differ  from one-layered  epithelia  not 
only by their different cell and tissue architecture  but also by 
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ber of cytokeratins have been found primarily in stratified tis- 
sues, or in tissues with a potential to stratification, including 
cytokeratins 1-6 and 9-17 (5, 58, 68, 71, 88, 94), suggesting 
that their production may be somehow related to the stratifi- 
cation process. On the other hand, it is clear that during em- 
bryogenesis stratified epithelia are derived from simple epi- 
thelia, and these changes of morphology are accompanied by 
changes of cytokeratin expression (e.g., 4, 46, 62, 71, 84). 
Similarly, certain forms of localized stratification in a nor- 
mally one-layered epithelium,  be they pathological  ("squa- 
mous metaplasia') or normal (as in amnion epithelium; 71), 
are  characterized  by the  advent of certain  cytokeratins  in 
these regions. 
In agreement with the concept of changes of cytokeratin 
expression during stratification are reports that the "simple 
epithelial" cytokeratins 8 and 18 have not been found in most 
biochemical analyses of cytoskeletal proteins from stratified 
epithelia (2, 5, 9, 35,  58, 64, 65, 68, 83,  84). Correspond- 
ingly,  immunocytochemical studies using several monoclo- 
nal antibodies specific for the simple epithelial cytokeratins 
8 and/or  18 have not shown reactivity  in  several kinds  of 
stratified epithelia (12, 13, 34, 45, 54, 69, 70), with the excep- 
tion of the  sparse  neuroendocrine  cells that  can occur in 
some stratified epithelia (e.g., 46, 61, 76). In contrast, cyto- 
keratin 19 has been identified in cytoskeletal extracts and has 
been localized immunocytochemically in basal cell layers of 
some stratified epithelia but not of others (8,  19). Remark- 
ably, squamous cell carcinomas derived from stratified epi- 
thelia sometimes reveal,  over extended regions  or only in 
certain cell clusters, the presence of simple epithelial cyto- 
keratins, including components 8 and 18 (19, 54, 58-60; see, 
however, reference 12), which may be taken as an indication 
of changes of cytokeratin expression during malignant trans- 
formation.  Likewise,  simple  epithelial  cytokeratins  have 
been repeatedly found in cultures of cells derived from stra- 
tiffed epithelia and squamous cell carcinomas (7, 31, 73, 98, 
99; for cell lines apparently lacking these proteins see 35, 75) 
which might reflect changes of expression during culturing 
in vitro. 
In the course of immunocytochemical studies with certain 
monoclonal antibodies to simple epithelial cytokeratins we 
have sometimes observed positive reactions in certain cell 
layers or cell clusters of some stratified epithelia.  Because 
these observations were seemingly at variance with the nega- 
tive biochemical and immunocytochemical reports mentioned 
above, we have studied the expression of such cytokeratins 
in stratified epithelia in greater detail, using various cytoker- 
atin polypeptide-specific antibodies and the cDNA probes to 
cytokeratins 8 and  18 recently developed in our laboratory 
(50, 74). We show that simple epithelial cytokeratin~ can be 
expressed  in  stratified  epithelia  and  that  the  synthesis  of 
cytokeratin 8 is often more prominent in basal cell layer(s). 
We also emphasize that the pattern of expression of the sim- 
ple epithelial cytokeratins 8, 18 and 19 can exhibit drastic re- 
gional differences in the same epithelium. 
Materials and Methods 
Tissue Samples 
Small pieces of apparently normal ("uninvolved") tissues were obtained 
from patients during surgical excision of benign or malignant tumors (cf. 
58-60) or, in the case of gingiva and oral mucosa, during periodontal sur- 
gery (cL 65). A total of five different samples of esophageal tissue and four 
vaginal samples was included in the present study. Epidermal samples were 
taken during surgical removal of tattooed skin (generously provided by Dr. 
I. Moll, Department of Dermatology, Mannheim Medical School, Univer- 
sity of Heidelberg, Mannheim, FRG). In some cases, autopsy specimens 
were used for controls. For RNA extraction, tissue samples were directly 
frozen in liquid nitrogen. For immunolocalization and in situ hybridization 
experiments, tissue  samples  were preferably  frozen in  isopentane pre- 
cooled in liquid nitrogen to ,'o130°C. 
Preparation of  RNA 
Small pieces of tissue corresponding to 0.5-1  g of wet weight were ground 
to a fine powder at ,~70°C in a Teflon capsule containing a steel bullet in- 
serted into a dysmembrator (Braun,  Melsungen, FRG).  The powder was 
then homogenized in 4 M guanidinium isothiocyanate (in 0.1 M Tris-HCl, 
pH 7.5; 10 mM dithiothreitol (DTT); 5 mM EDTA). Half the volume of  cold 
ethanol was added and RNA was precipitated for more than 6 h at -20°C. 
The pellet (10,000 g; 10 rain) was resuspended in 7 M guanidinium-hydro- 
chloride buffer (in 0.1 M sodium acetate, pH 5.5, 10 mM DTT), extensively 
homogenized twice more, and nucleic acids were precipitated with ethanol. 
The fnal pellet was washed with 70%  ethanol, dried, and then dissolved 
in 10 mM Tris-HC1 (pH 7.0) containing 0.5% SDS,  10 mM NaCI,  1 mM 
EDTA, 1 mM MgCI2, and up to 1 mg/ml proteinase K (Boehringer, Mann- 
heim, FRG) and was incubated for 60 min at 60°C. Residual proteins and 
proteinase K were removed by three cycles of phenol/chloroform extraction. 
Preparation of  Radioactively Labeled cRNA Probes 
and Northern Blot Analysis 
These procedures were performed essentially as described (50). As cytoker- 
atin 8 mRNA probes we used either the transcript of the Bgl-linearized 
clone pKH8  ~ as previously described (50) or a shorter Sac I-Eco RI frag- 
ment of clone pKH8 ~ subeloned into Bluescribe (Stratagene, San Diego, 
CA) encompassing part of the tail region (for terminology see 84, 93) and 
the 3'-noncoding sequence, thereby minimizing possible cross-hybridiza- 
tion with other cytokeratin mRNAs. Clones in Bluescribe (pKH82)  were 
linearized with one of several restriction enzymes producing a protruding 
Y-end, before transcription in vitro with I"7 polymerase. The Barn HI-Eco 
RI fragment of clone pKH18 ' (50) was cloned in pTZ18 R (clone pKHI83), 
which was linearized. Clones pKH41 and pKH151 (51) were used for com- 
parison. For "dot blot" hybridization tests fivefold serial dilutions of total 
RNA were spotted on filters (Gene Screen Plus; New England Nuclear, Bos- 
ton, MA), using a Minifold II apparatus (Schleicher and Schuell, Dassel, 
FRG).  Hybridization conditions with cRNA probes were as in Northern 
blot analysis. 
Synthetic Oligonucleotides 
Our cytokeratin 18-specific cRNA probe (cf. 50) still contains a stretch of 
,~150 nucleotides, corresponding to the end of the a-helical rod portion. 
Since theoretically this sequence could cross-hybridize with other type I 
cytokeratins, albeit only at reduced stringency, we have synthesized a 30 
nucleotides-long oligonucleotide 5' d(GCT CCC CAA AGG GTA  CCC 
TGC TTC TGC TC~) 3', complementary to the mRNA strand in the non- 
coding 3' region, encompassing positions 1278 to 1307 (50). We have also 
synthesized an oligonucleotide of n  =  30 complementary to part of the 3'- 
non-coding region of the mRNA of cytokeratin 14 (55), the sequence being 
5' d(GIG AAG CAG GGT CCA GCT GIG AAG TGC TTG) 3'. The oligo- 
nucleotides were labeled at their 5'-ends with y-32pdATP using T4-polynu- 
cleotide kinase and were purified from unincorporated nucleotides by dena- 
turing PAGE, elution through glasswool and lyophilization. Alternatively, 
they were passed through a SepPak Cjs Cartridge (Waters Associates, Mil- 
ford, MA) and lyophilized. The specific activity of freshly labeled oligonu- 
cleotides was ,~2  ×  109 cpm/~tg oligonuclootide. For filter hybridizations, 
using the same hybridization solution as for cRNA probes, the hybridization 
was at 37°C, and filters were washed first at room temperature in 4×  SSC 
and 0.1% SDS, and finally in 0.1×  SSC and 0.1%  SDS at 37°C. 
In Situ Hybridization 
The procedure using cRNA probes was as described (50), except that the 
hybridizations were at 50°C. When oligonucleotides were used as probes, 
the hybridization solution was the same but the temperature of hybridization 
was 37°C, and the temperature during post-hybridization washing did not 
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in the use of oligonucleotides. An advantage of using oligonucleotides in- 
stead of cRNA probes for in situ hybridization protocols seems to be that 
proteinase K treatment  of the sections,  including postfixation,  is not re- 
quired, provided that sufiScient detergent (0.1-0.5 % SDS) is contained in the 
hybridization solution. 
Gel Electrophoresis 
Frozen sections of esophageal tissue were used for microdissection as de- 
scribed (58,  59),  and strips of tissue containing the basalmost 3-4 layers 
were separated from the upper layers.  Cytoskeletal material was prepared 
therefrom and  its protein composition  analyzed  by  two-dimensional gel 
electrophoresis (1, 58-60). 
Antibodies and Immunohistochemistry 
The following murine monoclonal antibodies were used in this and the ac- 
companying (51) study:  (a) antibody K~ 8.13, broadly cross-reactive with 
type II cytokeratins as well as with cytokeratin 18 (type I; 32; available from 
Bio-Makor, Rehovot, Israel); (b) antibody lu-5 reacting with various type 
I and type II cytokeratins (25; available from Boehringer, Mannheim, FRG); 
(c) antibody PKK1 reported to react with several epithelial cytokeratins (92; 
from Labsystems, Helsinki, Finland); (d) antibody TROMA 1 specific for 
cytokeratin 8 (44; kindly provided by Dr. R. Kemler, Max Planck-Institute 
for Immunology, Freiburg i.Br., FRG); (e) antibody Ks 8.1.42,  selectively 
reacting with cytokeratin 8 (from Progen Biotechnics, Heidelberg, FRG); 
(f) antibody M20 reacting with cytokeratin 8 (90; kindly provided by Dr. 
G. van Muijen); (g) antibody 6B10, specific for cytokeratin 4 (88; kindly 
provided by Dr. G. van Muijen); (h) antibody IC7, specific for cytokeratin 
13 (88); (i) antibody Ks 13.1 preferentially reactive with cytokeratin 13 (57; 
from Progen, Heidelberg, and Boehringer, Mannheim); (j) antibody CK-2 
specific for cytokeratin 18 (12, 13; from Boehringer, Mannheim, FRG); (k) 
antibody RGE-53 specific for cytokeratin  18 (69; from Paesel, Frankfurt, 
FRG); (1) antibody K~ 18.27 (IgG1) which is also specific for cytokeratin 
18, as determined by immunoblotting and immunocytochemistry (from Pro- 
gen, Heidelberg); (m) antibody K~ t8.18 specifically reacting with certain 
heterotypic complexes of cytokeratin  18 (26);  (n)  antibody Ks 18.174 (57; 
from Progen, Heidelberg); (o) human cytokeratin D-specific antibody A53- 
IB/A2 (42; K~ 19.2, from Progen, Heidelberg); (p) antibody K~ 19.2 specific 
for cytokeratin  19 of human and some other species (from Progen,  Hei- 
delberg). 
lmmunofluorescence microscopy, using secondary antibodies coupled to 
Texas-Red or rhodamine compounds or fluorescein, was as previously de- 
scribed (cf.  1, 61). 
Results 
In our previous gel electrophoretic analyses of cytoskeletal 
proteins from microdissected stratified epithelia (including 
epidermis from various body sites, gingiva, lingual, and oral 
mucosa, pharyngeal epithelium, esophagus, exocervix, va- 
gina, and penile mucosa; 2, 58-60,  64, 65; see also refer- 
ences 5, 6, 9, 35, 84, 86), the only simple epithelial cytokera- 
tin frequently, though not always, detected in appreciable 
amounts was cytokeratin 19. In some of these tissues such as 
esophagus, minor amounts of cytokeratins 8 were also occa- 
sionally seen (data not shown). However, given the technical 
limitations of the microdissection method and the general 
problem that contributions from the frequent glandular ducts 
(cf. 40) cannot be excluded, we could not make definitive 
conclusions as to the presence or absence of cytokeratins 8 
and 18 in the stratified epithelial cells. To examine the possi- 
bility that the genes for cytokeratins 8 and 18 are expressed 
in these epithelia, we have therefore applied in situ localiza- 
tion techniques, using cytokeratin polypeptide-specific anti- 
bodies and cDNA probes  for cytokeratin mRNAs.  In the 
present report, we shall particularly concentrate on esopha- 
geal tissue, because this is the non-epidermal stratified epi- 
thelium most widely studied biochemically with respect to 
its cytokeratin pattern in both man (5, 6, 31, 35, 58, 59, 94) 
and animals (9, 20, 56) which has also been taken as a proto- 
type tissue for a group of non-epidermal stratified epithelia 
("esophageal-epithelial type of differentiation"; 9, 10, 83, 84). 
Reactivity of  Antibodies Specific for Simple Epithelial 
7)lpe Cytokeratins on Stratified Epithelia 
As  expected,  all antibodies to cytokeratins 8,  18,  and  19 
reacted intensely with the mucinous and the serous acini of 
the esophageal glands and their ducts, including the intra- 
epithelial ostia (results not shown; cf. 8), in contrast to the 
lack of reactivity reported with other cytokeratin antibodies 
by Hopwood et al.  (40).  However,  results obtained in the 
stratified epithelium were rather variable between different 
samples or different regions of the sample as well as between 
different antibodies reactive with the same cytokeratin poly- 
peptide. 
Fig. 1 presents results ofimmunofluorescence  microscopy, 
using a number of different monoclonal antibodies specific 
for the three simple epithelial cytokeratins 8,  18, and 19 on 
human esophageal epithelium. In the samples shown in Fig. 
1, antibody PKK1, reported to react with several cytokeratins 
including components 8,  18 and 119, selectively stained the 
cells in the basal layer (Fig. 1, a and b), regionally also with 
the first and second suprabasal layers although usually with 
lower intensity. Antibodies to cylokeratin 8 reacted differ- 
ently. All three of them (TROMA  1,  M20 and Ks 8.1.42) 
reacted strongly with a certain type of sparse cells located 
within or near to the basal cell layer, in a manner reminiscent 
of the distribution of the "Merkel cells" of epidermis (cf. 61), 
which were probably esophageal neuroendocrine cells (data 
not shown). In addition, antibody Ks 8.1.42 stained, in sev- 
eral but not all samples, many more cells of the basal layer, 
locally also groups of suprabasal cells (Fig. 1, c and d). Anti- 
body M20 also stained, in several samples, the basal cell 
layer and some suprabasal cells, although with somewhat 
lower intensity (not shown). However,  in other samples all 
three cytokeratin 8  antibodies were negative on the non- 
Merkel type cells of the basal layers. 
In many samples of esophageal tissue, both cytokeratin 
19-specific antibodies reacted with the basal cell layer but ex- 
hibited marked regional differences: In some regions the 
staining was restricted to the basal layer (Fig. 1, e and f), in 
others a substantial number of cells in the lower suprabasal 
compartment was also positive (Fig. 1 g), confirming recent 
findings of Bartek et al.  (8). 
The monoclonal antibodies specific for cytokeratin 18 gave 
grossly different results, varying both between different sam- 
ples and diffeent regions of the same sample. Some of them 
such as antibodies CK-2, RGE-53 and Ks 18.27 were nega- 
tive on the esophageal cells (data not shown) and reacted 
only with the individual sparse cells of putative neuroendo- 
crine character, in agreement with previous reports (e.g., 13, 
69).  The conformation-dependent antibody Ks  18.18, how- 
ever, reacted, regionally, with the basal layer (Fig.  1, i and 
j), in some places also with moderate reactivity in the lower 
suprabasal compartment (not shown). In contrast, the very 
sensitive, cytokeratin 18-specific antibody Ks 18.174 stained, 
in a number of  places, some suprabasal cell layers in addition 
to the basal cells (Fig.  1 h). These differences of immuno- 
staining between different antibodies to the same polypeptide 
and between different samples of esophageal tissue could not 
Bosch et al.  Simple Epithelial Cytokeratins:  Expressions in Stratified Tissue  1637 Figure I. Immunofluorescence  microscopy of frozen sections of  human esophagus,  showing examples of  differential reactivity of monoclonal 
antibodies  specific for simple epithelial  type cytokeratins.  E, epithelium;  L, lumen; LP, Lamina propria. The arrowheads  point to circular 
structures  that are either ostia of glandular ducts or protrusions of the Lamina propria.  (a and b) Antibody PKK1, reactive  with several 
cytokeratins including components 8, 18, and 19, staining exclusively the basal cell layer (demarcated by brackets in b); (a) epifluorescence; 
(b) phase-contrast  picture of the same field. (c and d) Monoclonal antibody K, 8.1.42 specific for cytokeratin  8 staining the basal cell layer 
(denoted by brackets  in d) and some isolated  suprabasal  cells (arrows in c).  (c) Epifluorescence;  (d) phase-contrast  optics.  (e, fand g) 
Cytokeratin 19-specific antibody A53-B/A2  (Ks 19.1) in different areas  of esophageal  epithelium.  The fluorescence  is either restricted  to 
basal  cells  (demarcated  by brackets  in f) with a few weakly stained  suprabasal  cells  (arrows in e; e, epifluorescence;  f, phase contrast) 
or extends to numerous suprabasal  cells (g). (h) Cytokeratin 18-specific antibody K~ 18.174 stains, in this sample, basal cell layers as well 
as several suprabasal  cell layers, although  with lesser intensity  in the latter.  (i and j) Antibody K~ 18.18, also reactive with cytokeratin  18 
containing  IFs, stains, in this sample,  predominantly cells in the basal layer (i, epifluorescence;  j, phase contrast; brackets  as in a). Bars: 
(a-i) 100 tam; (j) 50 Ixm. 
The Journal of Cell Biology. Volume 106, 1988  1638 Figure 2. Immunofluorescence microscopy of frozen sections  of samples  of human vagina,  showing different patterns  of reactivities  with 
various cytokeratin  antibodies  (symbols as in Fig.  1). (a) Uniform staining throughout all epithelial  layers after reaction  with broad range 
cytokeratin  antibody K~ 8.13. (b-e) Reactions  of antibody Ks 8.1.42 against  cytokeratin  8, showing a region with  strong staining  of basal 
and some suprabasal  cells  (b, epifluorescence;  c, phase contrast)  and a region with an abrupt change from positive  to negative reactivity 
(d,  epifluorescence;  e, phase contrast; upper bracket denotes lower suprabasal  compartment, lower bracket shows basal cell layer).  The 
significance  of this  local change of reactivity  is indicated  by the reactivity  of all layers with broad range cytokeratin  antibodies  such as 
Kg 8.13 in parallel  sections.  (f-i) Distribution  of cytokeratin  19-positive cells as detected  by antibody A53-B/A2. The fluorescence  is pre- 
dominantly over the basal  cell  layer (f, epifluorescence;  g, phase  contrast optics),  with  some local  suprabasal  positive  cell  clusters  (h, 
epifluorescence;  i,  phase contrast).  Bars,  50 tam. Figure 3. Immunofluorescence  microscopy of frozen sections of the same sample of human vagina, showing differential reactivity with 
various monoclonal antibodies to cytokeratin 18 (symbols as in Fig. 1). (a and b) Antibody CK-2 shows negative reaction throughout all 
epithelial cell layers (a, epifluorescence; b, phase contrast). (c) Antibody Ks 18.18 stains selectively the basal cell layer (bracket). (d) An- 
tibody K~ 18.174 reacts with most cells in all layers of vaginal epithelium. Bars, 50 ~tm. 
be correlated with differences of anatomical topology, e.g., 
upper vs.  lower esophagus. 
Such differential reaction patterns with antibodies to sim- 
ple epithelial cytokeratins were not unique to the esophagus 
but were also seen in some samples of other stratified squa- 
mous epithelia, though not in all. For example, results ob- 
tained for a sample of human vaginal epithelium in which 
differences of immunostaining were particularly apparent, 
are shown in Figs. 2,  a-i and 3,  a-d.  While broad range 
cytokeratin antibodies  such as  Kc  8.13 reacted uniformly 
with all epithelial layers, thus demonstrating the immunocy- 
tochemical availability of the cytokeratin IFs present in this 
tissue, some of the antibodies specific for simple epithelial 
cytokeratin showed very selective staining patterns. For ex- 
ample,  in  some regions  cytokeratin 8  antibody K~  8.1.42 
strongly stained the basal cell layer and some cells of the 
lower suprabasal compartment (Fig. 2, b and c), whereas in 
other regions such as that shown in Fig. 2, d and e, abrupt 
changes from strong positive staining of the basal cell layer 
and the lower suprabasal compartment to complete negativ- 
ity were seen (Fig. 2, d and e). Staining with both cytokeratin 
19 antibodies showed, in most regions, homogeneous stain- 
ing of the basal layer but local clusters of positively stained 
cells in the lower suprabasal compartment (Fig. 2, f-i) were 
sometimes also seen. essentially in agreement with Bartek 
et al. (8). 
As described above for esophagus, different cytokeratin 18 
antibodies yielded different results also on vaginal epithe- 
lium: In the sample shown in Fig. 3, antibodies CK-2, RGE- 
53, and K~ 18.27 were all negative (for an example see Fig. 
3, a  and b), with the exception of certain dispersed, prob- 
ably neuroendocrine ceils (not shown).  Antibody Ks  18.18 
stained predominantly the basal cell  layer (Fig.  3  c)  but 
regions without any significant reaction were also noticed. 
Antibody K~ 18.174 did react, in the sample shown in Fig. 3 
d,  not only with the basal cell layer but,  in many sample 
places, also with several suprabasal layers, often throughout 
almost the entire epithelium. 
As in esophagus, the immunoreactivities for cytokeratins 
8 and 18 in vaginal tissue also varied from sample to sample. 
Positive  immunocytochemical reactions  with certain anti- 
bodies to cytokeratin 8, 18 and 19 were occasionally also seen 
in some samples of other stratified epithelia, mostly in basal 
cell layers, such as the exocervix (see also references 8 and 
19), gingiva, oral and lingual mucosa, adult anal epidermis, 
and fetal epidermis (week 13-20), but not in normal adult in- 
terfollicular epidermis (data not shown). Again, in all these 
tissues the intensity and the distribution of the reaction var- 
The Journal  of Cell Biology,  Volume 106, 1988  1640 Figure 4.  Detection  of cytokeratin 8  and  18  mRNA in  human 
esophageal RNA by hybridization ("dot blot") analysis. Fivefold 
serial dilutions (0.2,  1, and 5 p.g, from top to bottom) of total RNA 
extracted from a simple epithelium (colon, upper panel, a-d) and 
a stratified epithelium, esophagus (lower panel, e-h) were hybrid- 
ized with 32P-labeled cRNA probes for cytokeratin 4  (a and e), 
cytokeratin 8 (b and f), cytokeratin 15 (c and g) or a 3ZP-labeled 
synthetic oligonucleotide specific for cytokeratin 18 (d and h). Ex- 
posure time for the cytokeratin 8 and 18 mRNA-probed filters was 
120 h; the filters probed for cytokeratin 4 and 15 mRNAs were ex- 
posed for 40 h. Note intense mRNA reactivity for cytokeratins 8 
and 18 in colon (b and d) and weak reaction in esophagus (fand 
h) whereas mRNAs for cytokeratins 4 and 15 are only detected in 
esophageal RNA (e and g) but not in colon RNA (a and c). 
ied somewhat in different samples and in different regions of 
the same sample. 
Examples of immunocytochemical staining of antibodies 
to simple epithelial cytokeratins selective for basal cell layers 
were also observed in stratified epithelia (esophagus, tongue, 
vagina) of some animal species such as Syrian hamster and 
cow (our unpublished results). 
Antibodies to cytokeratin 7 were negative on all stratified 
epithelia examined, in agreement with Ramaekers et al. (70). 
Detection of  mRNA for Cytokeratins 8 and 18 in RNA 
Extracted from Esophagus 
To provide a control for the immunocytochemical results ob- 
tained with some of the antibodies specific for simple epithe- 
lial  cytokeratins,  we  have  probed  for  the  corresponding 
mRNAs using nucleic acid hybridization on filters. To this 
we have extracted total RNA from tissue samples of various 
epithelia, esophagus included, blotted ihe RNA samples and 
hybridized them with antisense riboprobes and oligonucleo- 
tides (see Materials and Methods). The specificity and high 
sensitivity  of the  antisense  riboprobes  derived  from  our 
cDNA clones to cytokeratins 8 and 18 has been demonstrated 
previously by Northern blot analysis of total RNA extracted 
from different mammary carcinomas as well as by in situ hy- 
bridization to frozen sections of mammary carcinomas (50). 
As expected, mRNAs of cytokeratin 8 and 18 were present 
in positive control tissue samples such as colon in apprecia- 
ble amounts (Fig. 4, b and d). However, both mRNAs could 
also be detected in RNA from esophagus, although in much 
lesser quantities (Fig. 4,fand h). Vice versa, riboprobes de- 
rived from cDNA clones encoding cytokeratins 4 and 15 (51) 
gave strong reactions with esophageal RNA (Fig. 4, e and 
g) but not with colon RNA (Fig. 4, a  and c), in agreement 
with previous reports of a lack of these proteins in intestinal 
and colonic cells (58). While these findings showed that the 
genes encoding cytokeratins 8 and 18 were expressed some- 
where in the esophagus they did not allow to decide whether 
these mRNAs came from glandular duct elements and/or the 
sparse neuroendocrine cells or whether they were also pres- 
ent in the cells of the stratified epithelium. 
Localization of  Cytokeratin 8 and 18 mRNA by 
Hybridization In Situ 
For in situ hybridization, frozen sections of  esophageal tissue 
were fixed in 4% formaldehyde, proteinase K-treated, post- 
fixed and  hybridized with antisense cRNAs ("riboprobes") 
complementary to  3'-regions of mRNAs of cytokeratins 8 
and  18 as previously described (cf. 50), except that we in- 
creased the stringency of hybridization by raising the temp- 
erature  to  50°-52°C.  Fig.  5  presents  two  micrographs  of 
different areas of the same esophagus hybridized with the 
3H-labeled cRNA probe of cytokeratin 8,  showing a mark- 
edly positive reaction in the basaimost cell layer of the epi- 
thelium.  Label  in  the  upper  strata  of the  epithelium  was 
much weaker, and the silver grain density over elements of 
the Lamina propria was not significantly above background. 
In histological survey pictures of some sections (Fig.  6) a 
marked enrichment of autoradiographic silver grains can be 
seen over the basal cell layer and in certain epithelial forma- 
tions which represent ostia of glandular ducts or the basal 
cell layer of Lamina propria protrusions. Only locally, sig- 
nificant  silver  grain  densities  were  also  seen  over  small 
clusters of cells in the lower suprabasal compartment. 
In the tissue sample shown in Figs. 5-7 the distribution of 
cells containing cytokeratin  18  mRNA  was  quite different 
from that of cytokeratin 8-expressing cells. In general, cell 
labeling obtained for cytokeratin 18 mRNA was much weaker 
than that obtained for cytokeratin 8.  Remarkably, however, 
these weak, though significant signals were not restricted to 
the basal layer. Fig. 7 a shows a low magnification dark field 
photomicrograph after hybridization with a  3H-labeled cy- 
tokeratin  18 cRNA probe and long exposure time in which 
all cell layers of the epithelium are rather uniformly labeled. 
In Fig.  7 b,  a  small area of the same esophagus section is 
shown at higher magnification, using bright field illumina- 
tion, to facilitate the visualization of the sparse individual sil- 
ver grains. Only locally did we notice a weak enrichment in 
the basal cell layer. 
As our cDNA probe for cytokeratin 18 contained a stretch 
of sequence coding for the Q-helical part of the polypeptide, 
due  to  the absence of suitable  restriction sites  within the 
3'-noncoding portion of the cDNA clone, we could not for- 
mally exclude the possibility of cross-hybridization of our 
cRNA probe with mRNAs encoding other type II cytokera- 
tins, despite the high stringency of hybridization. We have 
therefore repeated the in situ hybridizations with a 5'-32P-la  - 
beled  synthetic oligonucleotide complementary to  30  nu- 
cleotides within the 3' non-coding portion of cytokeratin 18 
mRNA, which displays no significant homology to any other 
cytokeratin sequence thus far known. The hybridization sig- 
nal  obtained  was  similar  to  that  described  for the  cRNA 
Bosch  et  al.  Simph, Epithelial Cytokeratins:  Expressions in Stratified Tissue  1641 Figure 5. Microscopic autoradiographs  of frozen section stained with hematoxylin and eosin, showing enrichment of cytokeratin 8 mRNA 
in the basal cell layer of human esophagus epithelium (E) by in situ hybridization with pKH8  2. The tritiated cRNA probe of cytokeratin 
8 hybridized predominantly to the basal cell layer (brackets). In a, label is very weak in upper strata; in b label is not significantly above 
background, as seen from comparison with the Laminapropria  (LP) and its components (a, survey picture; b, higher magnification). Bars, 
25 lam. 
The Journal of Cell Biology, Volume 106. 1988  1642 Figure 6. Survey autoradiomicrograph (dark-field illumination) of frozen section of esophagus, showing hybridization with the 3H-labeled 
cytokeratin 8 cRNA probe. The brackets demarcate the basal cell layer which shows enrichment of label. Triangles point to intensely labeled 
circular structures, probably protrusions of the Lamina propria (symbols as in Figs. 1-3 and 5). Bar, 250 Jam. 
probe, showing rather uniform labeling over the entire epi- 
thelium (data not shown). 
In epidermis, cytokeratins 5 and 14 have been reported by 
immunocytochemistry and hybridization in situ to occur in 
the basal cell layer but also in several suprabasal layers (cf. 
87, 95). Since these two cytokeratins are also present in the 
esophagus, as shown by two-dimensional gel electrophoresis 
(58),  we  used a  synthetic oligonucleotide (n  =  30)  com- 
plementary to  the  3'  non-coding  region of cytokeratin  14 
mRNA (55) for comparison. On Northern blot hybridization 
with total RNA extracted from human epidermal tissue, this 
oligonucleotide probe selectively detected a mRNA band of 
~1.6 kb, whereas no hybridization was seen with total RNA 
from colon (data not shown). On the other hand, the cytoker- 
atin 18-specific  oligonucleotide (n  =  30, see above) hybrid- 
ized with a single mRNA band of 1.4 kb from colon but did 
not hybridize to epidermal RNA (data not shown). In situ hy- 
bridization using the cytokeratin 14 oligonucleotide on fro- 
zen sections of esophagus yielded a uniform hybridization 
reaction to all cell layers, including the basal one (Fig. 8 a). 
When the same type of experiment was done for controls on 
human epidermis (Fig. 8, b and c), predominant but not ex- 
clusive synthesis of cytokeratin 14 mRNA was seen in basal 
layers, with appreciable amounts still detected in the upper 
strata, confirming earlier work of others (e.g., 27, 28, 83, 84, 
95).  We conclude that cytokeratin 14 mRNA expression in 
esophagus,  as  in  epidermis,  is  not  restricted to  the  basal 
layer. We have also not seen significant in situ hybridization 
for cytokeratin 8 and 18 mRNAs in interfollicular epidermis 
(data not shown). 
Adjacent sections were also examined for the expression 
of mRNA encoding cytokeratin 4, the most abundant type II 
cytokeratin of esophageal  epithelium  (58),  and  the type I 
cytokeratin 15 also present in substantial amounts (58;  see 
also Fig. 9). The results, presented elsewhere (51), showed 
intense labeling for cytokeratin 15 mRNA in all layers, and 
preferential cytokeratin 4 mRNA labeling of suprabasal ceil 
layers,  with  additional  label  of the  basal  layer  in  some 
regions. 
Gel Electrophoresis 
To enrich cytoskeletal proteins of basal cell layers we have 
used esophageal tissue with few, if any, glandular ducts and 
have separated, by microdissection of frozen tissue sections, 
upper epithelial layers from material including the 3-4 basal 
layers, with some adjacent Lamina propria material. Two- 
dimensional gel electrophoresis using sensitive silver-stain- 
ing methods for detection and co-electrophoresis with au- 
thentic cytokeratins for identification (Fig.  9, a  and b;  see 
also Materials and Methods) we confirmed the abundance of 
cytokeratins 4-6 and 13, together with moderate amounts of 
cytokeratins 14-17, as described previously (58,  59,  68). In 
addition,  we  found,  in  heavily  loaded  gels,  considerable 
amounts of cytokeratin 19 and small amounts of cytokeratin 
Bosch  el  al.  Simple Epithelial Cytokeratins:  Expressions in Stratified Tissue  1643 8 (Fig. 9 b). We noted only faint staining in the position of 
cytokeratin 18 which, however, was too weak and too close 
to the major spot of residual actin to be considered as evi- 
dence of  the existence ofcytokeratin 18 in these analyses. The 
gel electrophoretic results made evident that the amounts of 
cytokeratins 8 and  18 in this tissue are very low. 
Discussion 
The results of this study show that the expression of genes 
encoding  cytokeratins of the  simple  epithelial  type,  i.e., 
polypeptides 8, 18 and 19, is not necessarily restricted to sim- 
ple epithelia but can also occur in stratified epithelia. While 
the total amounts of cytokeratin 19 found in various nonepi- 
dermal stratified epithelia, esophagus included, are usually 
sufficient to be identified among the abundant cytokeratins 
characteristic for stratified epithelia in gel electrophoretic 
analyses (e.g., 58-60), the concentrations of cytokeratin 8, 
and even more so of cytokeratin 18, are very low, if detectable 
at all. Obviously, we cannot exclude that the minor amounts 
of some simple epithelial cytokeratins occasionally seen in 
gel  electrophoretic analyses  are  contributions  from  cells 
other than the stratified esophageal cells such as neuroendo- 
crine and glandular elements. The same reservations apply 
to reports of the occurrence of small amounts of cytokeratin 
18 mRNA in human exocervix (74) as well as of cytokeratin 
8 mRNA in human (this study) and bovine (53) esophagus. 
However, our in situ localization results with specific anti- 
bodies and mRNA probes prove that indeed some cytokera- 
tin 8 and  18 can occur in cells of stratified tissue. 
We conclude that the synthesis of cytokeratins 8,  18, and 
19 is, in principle, compatible with the formation and differ- 
entiation of  a stratified epithelium and that the disappearance 
of simple epithelial cytokerafins is not a necessary prerequi- 
site for the development and maintenance of a stratified epi- 
thelium. Rather, our observations indicate that these simple 
epithelial  cytokeratins are  frequently,  but  not  always,  ex- 
pressed  in  many  nonepidermal  stratified  epithelia  where 
cytokeratins 8 and  19 often, but not always,  are enriched in 
the basal cell layer(s). The concept of a continual expression 
of simple epithelial cytokeratins in stratified epithelia is also 
in agreement with the gel electrophoretical and immunocyto- 
chemical findings of cytokeratins 8,  18, and 19 in several de- 
veloping stratified epithelia, including esophagus, of human 
fetuses of week 16-20 (54, 71). Whether the relatively small 
amounts  of these  simple  epithelial  cytokeratins in certain 
Figure 7. Microscopic autoradiographs of frozen sections of human 
esophagus, showing expression of cytokeratin 18 mRNA in basal 
and suprabasal cell layers (symbols as in previous figures) after hy- 
bridization in situ with pKH183 (see Materials and Methods). (a) 
Low magnification survey picture (dark-field photomicrograph), 
showing weak labeling over the entire epithelium from basal cells 
(indicated by brackets; dashed line demarcates basal lamina) to the 
lumen. The section was exposed to Kodak NTB2 emulsion for 50 d 
(silver grain densities over lumen, (L) and Lamina propria,  (LP) 
represent background). (b) High magnification bright field micro- 
graph taken from the same esophagus section, showing the weak, 
uniform hybridization signal over the basal cell layer (brackets) and 
several suprabasat layers. Bars: (a) 250 gm; (b) 25 p.m. 
The Journal of Cell Biology,  Volume 106, 1988  1644 Figure 8. Autoradiomicrograph of frozen sections of human esophagus (a) and epidermis (b and c) hybridized with a y-32p-dATP-labeled 
synthetic oligonucleotide specific for human cytokeratin 14. (E) epithelium; (LP) Laminapropria; (D) dermis; (EP) epidermis. (a) Silver 
grain distribution over basal and suprabasal cell layers of esophagus (bracket, basal layer). (b and c) Enrichment of cytokeratin 14 mRNA 
in the basal compartment (brackets in b; broken line in c shows basal lamina) of epidermis but not that significant label also extends into 
the suprabasal layers. Proteinase K treatment was omitted in this specific experiment. (b) Bright field; (c) dark-field illumination. Bars, 
50 ~tm. 
stratified epithelia serve special functions, for example, in 
the basal cell layers, remains to be seen. 
Taking together our results on the distribution of mRNAs 
encoding cytokeratins 4, 8, 14, 15,  18, and 19 (this study and 
reference 51)  in  esophagus,  we  further conclude that  the 
genes  encoding  simple  epithelial  cytokeratins can  be  co- 
expressed with other cytokeratins such as 4,  13,  14, and  15 
which are characteristic of stratified epithelia (for in situ hy- 
bridization of mRNAs  encoding stratification-related cyto- 
keratins in other tissues see also references 72 and 87). This 
indicates that the principles regulating the expression of the 
genes encoding simple and stratified epithelial cytokeratins 
are not necessarily mutually exclusive but may allow, at least 
in  certain  cells,  that  both  groups  of cytokeratins are co- 
expressed. 
Our  demonstration that different monoclonal antibodies 
specific for the same cytokeratin polypeptide may react dif- 
ferently on the same tissue questions the general validity of 
judgments of the absence of a given protein based on single 
epitopes. We have no experimental evidence to explain why, 
in the same tissue block, certain antibodies to cytokeratin 8 
stain only the sparse  individual,  probably neuroendocrine 
cells whereas others such as antibody Ks  8.1.42  stain pri- 
marily the basal cell layer(s), or why some cytokeratin 18- 
Bosch  et  al.  Simple Epithelial Cytokeratins:  Expressions in Stratified Tissue  1645 Figure 9. Two-dimensional gel electrophoresis of cytoskeletal pro- 
teins (NEPHGE, direction of nonequilibrium pH  gradient elec- 
trophoresis in first dimension; [SDSI SDS-PAGE in second dimen- 
sion) of microdissected basal cell layers from frozen sections of 
human esophagus as seen after silver staining. (a) Moderate protein 
load (B), BSA: (P) 3-phospho-glycerokinase from yeast; (A) actin, 
were used as  reference proteins).  (b)  Heavy loading. Identified 
cytokeratins are numbered; the arrow denotes the position of cyto- 
keratin 18 at the upper margin of the actin spot which is hardly de- 
tectable. (V) vimentin from contaminating nonepithelial cells. 
antibodies are negative in all strata, whereas others stain pre- 
dominantly the basal  layer(s) alone or together with some 
suprabasal  layers.  At  least  in  certain  samples,  as  shown 
above, the latter, more extended reaction corresponds to the 
in situ hybridization result,  underlining its credibility. The 
most likely explanation for such different immunocytochem- 
ical results with different monoclonal antibodies to the same 
proteins seems to be differential masking of the specific epi- 
topes by conformational folding or by interaction with other 
cellular components. Cell type-selective masking of IF pro- 
tein epitopes in relation to processes of cell differentiation 
(e.g.,  11, 48, 95), cell cycle (e.g., 18, 23) and cell metabolism 
(15, 38) is apparently a rather widespread phenomenon and 
therefore should always be considered as a possible explana- 
tion for unexpected negative findings. Interestingly, antibody 
K~  18.174 is not only very sensitive in immunoblotting but 
also differs from the other cytokeratin 18-antibodies  in that 
its  epitope  is  not  located  in the a-helical  rod (our unpub- 
lished results). Future detailed mapping of the epitope(s) of 
the various antibodies should help in the elucidation of the 
changes responsible for the selective negativity of some epi- 
topes in some cells and cell layers. 
Another unexpected and puzzling finding of our study is 
the frequency of regional differences of both the immunocy- 
tochemical and  in situ  hybridization reactions in the same 
sample as well as between samples from different donors. At 
present we do not know whether these regional differences 
represent "stable" localized differentiations or reflect local 
responses of the tissue to proliferative stimuli, local inflam- 
mation, or other environmental influences. Positive effects of 
certain environmental factors such as the concentration of 
vitamin A on the synthesis of simple epithelial cytokeratins 
have been demonstrated in cell cultures (e.g., 29, 33, 43, 97). 
The enrichment of cytokeratin 8 mRNA and protein, to- 
gether with sizable amounts of cytokeratin 19,  in the basal 
cell layer, is particularly interesting in relation to the demon- 
strated high proliferative potential and the special immuno- 
reactivities of this layer in various epithelia, epidermis in- 
cluded (e.g.,  14, 41, 46, 47, 66, 78, 89-91, 95). Clearly, it is 
this basal region in which most cell divisions take place, and 
it is also the proliferatively more active basal  layers which 
probably give rise to the formation of squamous cell carci- 
nomas.  Therefore, it is conceivable that the occurrence of 
cytokeratins 8,  18,  and  19  in  certain  squamous  cell  carci- 
nomas,  albeit  in  low  amounts  and  variable  (19, 58-60), 
results from the selective proliferation of cells of the basal 
compartment of these tissues during malignant growth. Like- 
wise, the widespread occurrence of cytokeratins 8,  18, and 
19 in cultured cells derived from squamous stratified epithe- 
lia and carcinomas (for references see Introduction) might 
reflect the maintained expression of these proteins in cells 
derived from the proliferative basal compartment which are 
selected during growth  in vitro.  Of course,  we cannot ex- 
clude the  alternative possibility,  i.e.,  the  induction or  in- 
crease of synthesis of cytokeratins 8, 18, and 19 during trans- 
formation and tumor growth, and we are aware of reports 
showing  the  appearance of these cytokeratins upon trans- 
formation of epidermal keratinocytes by simian virus SV40 
(63,  85). 
Cytokeratins 8 and  18 appear,  in many simple epithelia, 
as a "pair" forming the tetrameric heterotypic subunits of two 
chains each (67). Our finding of a different distribution pat- 
tern of the concentrations of mRNAs  encoding these  two 
polypeptides in the various layers of esophageal epithelium 
shows  that  the  synthesis  of these  two  cytokeratins is  not 
necessarily  coupled  but  may  be  regulated  independently. 
Clearly, cytokeratin 8 can pair with other type I cytokeratins 
such as No.  19 (for examples see intestinal epithelium and 
cerain cultured cell.lines such as MCF-7) to form IFs. Future 
studies in other epithelia and in animal tissues will be needed 
to examine the general validity of our findings with human 
esophagus. 
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